Role of intravitreal triamcinolone as an adjuvant in the management of Vogt-Koyanagi-Harada disease

Moreker, Mayur R.; Lodhi, Sikander A.; Pathengay, Avinash
November 2007
Indian Journal of Ophthalmology;Nov2007, Vol. 55 Issue 6, p479
Academic Journal
clinical trial
No abstract available.


Related Articles

  • How to identify, manage Vogt-Koyanagi-Harada disease. Cunningham Jr., Emmett T. // Ophthalmology Times;6/1/2005, Vol. 30 Issue 11, p51 

    Studies the nature of the inflammatory eye disorder, Vogt-Koyanagi-Harada disease. Characteristics of the disease; Therapeutic approaches for the condition; Ways of managing the disease; Neurologic symptoms of the disease.

  • Fluocinolone acetonide/triamcinolone.  // Reactions Weekly;Jul2014, Vol. 1508 Issue 1, p18 

    The article presents a case study of a 66-year-old man who was diagnosed with cytomegalovirus (CMV) retinitis or acute retinal necrosis after being medicated with triamcinolone or fluocinolone acetonide for Vogt-Koyanagi-Harada disease with steroid-induced cataracts and ocular hypertension.

  • Sister cases of Behcet's disease and Vogt—Koyanagi—Harada disease. Horie, Yukihiro; Namba, Kenichi; Kitaichi, Nobuyoshi; Ohno, Shigeaki // British Journal of Ophthalmology;Mar2008, Vol. 92 Issue 3, p433 

    A letter to the editor is presented about sister cases of Behcet's disease and Vogt-Koyanagi-Harada disease.

  • Rock the Vogt.  // Review of Optometry;May2014, Vol. 151 Issue 5, p73 

    The article provides an answer to a question on when to co-manage uveitis or Vogt-Koyanagi-Harada (VKH) syndrome.

  • New insights into Vogt-Koyanagi-Harada disease. Damico, Francisco Max; da Silva, Felipe Theodoro Bezerra Gaspar Carvalho; Gasparin, Fábio; Yamamoto, Joyce Hisae // Arquivos Brasileiros de Oftalmologia;2009, Vol. 72 Issue 3, p413 

    Vogt-Koyanagi-Harada disease (VKH), a well-established multiorgan disorder affecting pigmented structures, is an autoimmune disorder of melanocyte proteins in genetically susceptible individuals. Several clinical and experimental data point to the importance of the effector role of CD4+ T cells...

  • Management of recurrent inflammatory choroidal neovascular membrane secondary to Vogt-Koyanagi-Harada syndrome, using combined intravitreal injection of bevacizumab and triamcinolone acetate. Pai, Sivakami A.; Hebri, Sudhira P.; Lootah, Afra M. // Indian Journal of Ophthalmology;Nov2012, Vol. 60 Issue 6, p551 

    The purpose of this report is to evaluate the efficacy and safety of combined intravitreal injection of bevacizumab and intravitreal triamcinolone acetonide (IVTA) for recurrent inflammatory choroidal neovascular membrane (CNVM). It was a prospective interventional study of a young female, who...

  • Intracerebral hemorrhages in Vogt-Koyanagi-Harada disease. Baheti, Neeraj N.; Cherian, Ajith; Kate, Mahesh; Krishnan, Syam; Thomas, Bejoy // Neurology India;Nov2009, Vol. 57 Issue 6, p815 

    A letter to the editor is presented which describes the case of a 26-year-old man with intracerebral hemorrhages in Vogt-Koyanagi-Harada disease.

  • Anti-SS-A Ro reactivity in patients with Vogt—Koyanagi—Harada syndrome. Shinzato, M.; Yamamoto, J.H.; Hirata, C.E.; Olivalves, E.; Bonfá, E. // Lupus;2004, Vol. 13 Issue 4, p279 

    Presents a letter to the editor concerning anti-SS-A/Ro reactivity in patients with Vogt-Koyanagi-Harada syndrome, an autoimmune disease.

  • Uveomeningeal syndromes involve variety of findings. Chavis, Pamela; Lee, Andrew // Ophthalmology Times;11/01/98, Vol. 23 Issue 21, p11 

    Features the uveomeningeal syndromes group of diseases involving the uvea, retina and the central nervous system. Vogt-Koyanagi-Harada's syndrome; Behcet's disease; Acute posterior multifocal placoid pigment epitheliopathy; Mycobacterial infection; Toxoplasmosis.

  • Steroids improve serous detachment. Chang, Andrew; Ciardella, Antonio // Ophthalmology Times;6/15/96, Vol. 21 Issue 18, p9 

    Presents a case of a 35-year-old black male diagnosed with Vogt-Koyanagi-Harada disease and was commenced on oral steroid therapy. Presenting signs and symptoms; Results of the steroid therapy.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics